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SUMMARY
A study was conducted to compare the effect of dexamethasone treatment prior to, during and post-vaccination on
antibody response and protection against experimental challenge with Mannhaemia haemolytica. Sixteen goats of
about 7 months old were divided into 4 equal groups. All goats were vaccinated twice intranasally with 1ml inoculum
containing 106 colony forming unit (cfu) of formalin-killed Mannhaemia haemolytica A2/ml. The two doses were
administered at 2-week intervals. Goats in group 1 were treated with dexamethasone prior to vaccination, group 2
was treated during vaccination, group 3 was treated at 1 week-post vaccination while group 4 remained as the vacci-
nated control. Serum samples were collected weekly for a period of 5 weeks to detect antibody using an ELISA. Two
weeks post-vaccination, all goats were challenged intratracheally with 4 ml inoculum containing live Mannhaemia
haemolytica at a concentration of 109 cfu/ml before slaughtering at 2 weeks post-challenge. The extent of pneumonic
lung lesions was determined. Generally, animals without dexamethasone treatment had significantly (p<0.05) high
antibody response compared to other groups while the extent of pneumonic lung lesions was significantly (p<0.05)
lowest. Although group 1 showed the second highest antibody response and a lower percentage of lesions, the
differences were significant (p<0.05) compared to the control group. Group 2 which showed the second lowest anti-
body response recorded significantly (p<0.05) extensive lung lesions while group 3, which showed the lowest anti-
body level had insignificantly (p<0.05) more extensive lung lesions. There were strong correlations between the
antibody response and the severity of lesions. The results emphasise that vaccination will not be efficient if carried out
when the animal is under stressful conditions.
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INTRODUCTION
Pneumonic pasteurellosis is one of the most common
diseases of sheep and goats throughout the world. It is
caused by either Mannhaemia haemolytica or
Mannhaemia multocida which have been recognised as
part of the normal flora of the nasopharynx (Dungworth,
1985). In Malaysia, most cases of this disease (70%) are
caused by Mannhaemia haemolytica type A (Jamaludin,
1993) and Mannhaemia haemolytica serotype A2 is the
most commonly isolated followed by serotypes A9 and
A7 (Bahaman et al., 1991; Mohamad et al., 1993).
The disease has been shown to be associated with
various stress factors including environmental factors
such as climatic changes, transportation and nutrition
deficiencies (Jubb et al., 1985; Zamri-Saad et al., 1989a;
Jasni et al., 1991). Concurrent infections such as parain-
fluenza type III virus and Haemonchus contortus have
also been shown to predispose animals to this disease
(Zamri-Saad et al., 1994).
Under the influence of stress factors, steroids are
released into the circulation leading to immunosuppres-
sion (Chiang et al., 1990). Thus, pathogenic organisms
such as Mannhaemia haemolytica are able to proliferate
in the upper reapiratory tract. A great number of these
organisms are inhaled into the lungs (Gonzalez and
Maheswaran. 1993), colonize in the lungs (Shewen, 1994)
leading to severe fibrinous pneumonia (Jericho, 1985)
and death.
Vaccination including the use of imported vaccines
has commonly being used to control the occurrence of
this disease with limited success (Wan Mohamad et al.,
1988; Zamri-Saad et al., 1989c). Although an improved
locally produced oil adjuvant vaccine has been shown to
increase antibody response (Zamri-Saad et al., 1993a)
and provided satisfactory protection (Chandrasekaran et
al., 1991; Zamri-Saad et al., 1993b), it is less popular
due to its high viscosity leading to lameness in ap-
proximately 10% of the herd (Jamaluddin, 1993). Re-
cently, a new pasteurella spray vaccine was developed,
which is easily administered and provides good protec-
tion against experimental challenge (Effendy et al.,
1998a; b; c). However, the protective duration was short
and limited to only 12 weeks (Zamri-Saad et al., 1993a).
It is generally believed that the antibody response
by vaccinated animals may be markedly reduced below
the protective level in the presence of stressful factors.
Steroids such as dexamethasone can be used to
determine whether stressful conditions cause failure of
animals to respond to vaccination.
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Thus, this study was conducted to determine the
effect of dexamethasone treatment prior, during and
post-vaccination on antibody response and protection
against experimental challenge of goats with
Mannhaemia haemolytica.
MATERIALS AND METHODS
Animals
Sixteen 7-month-old goats were selected and divided into
four groups. They were kept separately and were given
cut grass and supplemented food at the rate of700g/goat/
day. Drinking water was provided ad libitum throughout
the study.
Prior to the start of the experiment, nasal swabs were
collected from all goats twice a week for bacteriological
isolation to ensure that all of them were free of Pasteurella
haemolytica for at least 2 weeks.
Preparation of formalin-killed Mannhaemia haemolytica
A2 vaccine
Thirty uniform-sized colonies of Mannhaemia
haemolytica A2 isolated from pneumonic lung were in-
oculated into 50ml of Brain Heart Infusion (Bill) broth
and incubated at 37°C for 24 hours. The broth was seri-
ally diluted using peptone water (-1 to -10) before 100111
of each dilution was streaked onto blood agar and incu-
bated at 37°C for 24 hours. Standard Plate Count (SPC)
method was used to determine the bacterial concentra-
tion before the concentration was re-adjusted to give a
final concentration of 2.3 x 106 cfulml. The bacteria was
then killed using 10% buffered formalin to a final con-
centration of 0.5%.
Preparation of inoculum for experimental challenge
The procedure of growing Mannhaemia haemolytica A2
in the BID and the determination of bacterial concentra-
tion (cfu) using the SPC method as described above were
carried out for the preparation of the vaccine. The bacte-
ria cells were not killed and final concentration of this
inoculum was re-adjusted at a concentration of 109cful
ml.
Preparation of coating antigen for ELISA
The growth and incubation procedures of Mannhaemia
haemolytica A2 were as described earlier, except that
the organisms were killed by boiling at 97°C for 20 min-
utes. This was followed by washing 3 times in phos-
phate buffered solution (PBS) by centrifugation at 12,000
rpm for 15 minutes and the cells were re-suspended in
PBS coating buffer. The final product was dispersed into
several Eppendorf tubes and kept at -20°C to be used in
ELISA procedure.
Table 1.Summary of treatments
Group Dexamethasone. Vaccination
injection
1 Before first Double dose of
vaccination formalin-killed
vaccine at 1 week
interval
2 During vaccination Same
(at the interval
between first and
booster dose)
3 After booster dose Same
of vaccination
4 Not given at all Same
Experimental design
Table 1 summarises the experimental design. At the
start of the experiment, goats in group 1 were injected
intramuscularly with dexamethasone at a rate of lmg/kg
for three consecutive days. Three days after the last dex-
amethasone injection, all goats were vaccinated intrana-
sally with formalin-killed Mannhaemia haemolytica A2.
One week after the vaccination, goats in group 2 were
similarly injected with dexamethasone for three consecu-
tive days. The booster dose of the vaccine was similarly
administered to all goats 1 week after the initial vaccina-
tion. One week after the second vaccination exposure,
goats in group 3 were injected intramuscularly with dex-
amethasone at the same dosage for three consecutive days.
Goats in group 4 remained vaccinated without dexam-
ethasone injection (control). Serum samples were col-
lected from the jugular vein of all goats prior to the start
of the experiment and at weekly intervals thereafter.
One week after the second vaccination, all goats
were challenged with 4 ml inoculum containing live
Mannhaemia haemolytica A2 at a concentration of 109
cfu/ml. Clinical signs of respiratory tract infection (na-
sal discharge, body temperature exceeding 40.5°C,
coughing and respiratory difficulties) were monitored
daily and scored according to Zamri-Saad et al. (1996).
At the end of two week post-challenge, all goats were
slaughtered. The respiratory systems were examined
and the extent of pneumonic lung lesions was determined
according to Gilmour et al. (1983).
The serum samples were subjected to enzyme-linked
immunosorbent assay (ELISA) to determine the antibody
levels to Mannhaemia haemolytica A2 according to the
technique described by Puspa (1997) and Effendy et al.
(1998c).
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Enzyme-linked immunosorbent assay (EUSA)
The ELISA was carried out according to the method de-
scribed by Puspa (1997) and Effendy et al. (1998c). The
plates were coated with antigen and incubated either
at 37QC for 1 hour or at -4°C for 18hours prior to
incubation with serum (1:40 dilution) and the rabbit
anti-goat IgG conjugate (1:8000). The results were
recorded at optical density (OD) at 405 nm wavelength.
Statistical analysis
The differences in the antibody response between
groups were determined by means of One-WayANOYA
and Duncan Multiple Range Test, while the correla-
tion between the extent of lung lesions and the antibody
responses was determined by means of correlation
coefficient. All the data were tested at 5% level of sig-
nificance.
RESULTS
Antibody response
Generally, all groups except group 1, showed good
antibody responses after vaccination against
Mannhaemia haemolytica A2 (Figure 1). Prior to the
vaccination, all groups showed low antibody levels
against Mannhaemia haemolytica A2 but the antibody
levels in groups 2, 3 and 4 increased significantly
(P<0.05) following vaccination.
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Figure 1: Antibody responses following vaccination
against pneumonic pasteurellosis using spray
vaccine
Following injection of dexamethasone for three
consecutive days from day 0 in group 1, the antibody
levels were significantly (p<0.05) decreased at week 1
before returning to pretreatment level at week 2. Group
2 showed a significantly (p<0.05) increased antibody
level at week 1 following first vaccination. However,
the antibody levels were decreased significantly (p<0.05)
from the initial pretreatment level at week 2 follow-
ing dexamethasone injection just prior to the administra-
tion of the second vaccination at the end of week 1. Simi-
larly, group 3 responded well to the initial vaccination at
week 1but returned to the insignificant level of pretreat-
ment at week 2. Following dexamethasone injections
and challenge by Mannhaemia haemolytica A2 at the
end of week 2, the antibody level decreased significantly
(p<0.05). The control vaccinated group showed
significantly (p<0.05) increasing antibody level
following first and second vaccinations at weeks 0 and
1.Thus, the vaccinated control group was the only group
that had a significantly (p<0.05) higher antibody level
at the time of challenge with live Mannhaemia
haemolytica A2 at week 2.
Following challenge with live Mannhaemia
haemolytica A2 at week 2, all groups showed
significantly (p<0.05) decreased levels in their antibody
levels at week 3. There were signs of antibody level
recovery, particularly in groups 1 and 4 at week 4 prior
to slaughter.
Gross lung lesions
All goats were slaughtered on day 14 post-challenge
(week4).Approximately 66% of the goats had gross lung
lesions typical of pneumonic pasteurellosis. The affected
parts of the lung appeared dark red and firm with
distinct demarcation between the lesions and the normal
lung areas (Plate 1). Most lesions involved the anterior
and ventral parts of the lungs (Plate 2). The severity of
the lung lesions produced in infected goats is summarised
in Table 2.
Table 2. The average lung lesion score for groups of goats
receiving dexamethasone injections at different times
Group % Lung lesions
1
2
3
4
18.5
45.0
7.75
5.0
Correlation coefficient
Correlation coefficient was used to determine the corre-
lation between antibody response and the lung lesion
score. Overall, the results indicated that there was strong
correlation (r= 0.91). Goats with high antibody response
following vaccination showed less severe lung lesions
while goats under a stressful condition that had low anti-
body response, had more severe lung lesions.
DISCUSSION
The results indicate that double intranasal exposures
to formalin-killed Mannhaemia haemolytica A2 stimu-
late good antibody response in goats. Puspa (1997) has
documented that the intranasal exposures stimulate
higher systemic antibody response compared to other
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Plate I: The lung of a vaccinated goat challenged with
Mannhaemia haemolytica A2 following dexamethasone
treatment showing extensive areas of pneumonia.
Plate 2: The lungs of a vaccinated goat challenged by
Mannhaemia haemolytica A2 following dexamethasone
treatment showing consolidation of the antero-ventral lobe,
type of vaccination and it also protects the goats from
experimental challenge.
Generally, all groups had an average low antibody
level prior to vaccination. This is probably due to the
previous natural exposures to Mannhaemia haemolytica.
After the first vaccination, all groups showed an imme-
diate increase in the antibody titer except for group 1,
which received dexamethasone injection prior to
the vaccination. Therefore, dexamethasone injections
prior to vaccination in this study significantly decreased
the initial antibody level. Similar results were observed
following administration of dexamethasone during
(group 2) or after (group 3) vaccination. Dexametha-
sone has been known to produce an immunosuppressive
effect on animals by suppressing neutrophil function
and anti-microbial activity of alveolar macrophages
(Jasni et al., 1991). It is believed that, like dexametha-
sone, stressful conditions compromise the defense
mechanism of the respiratory tract, allowing prolifera-
tion and persistence of Mannhaemia haemolytica in the
nasal cavity (Effendy, 1998), causing the loss of epithe-
lial cilia, erosion and rhinitis. These lesions have been
recognised as key factors in the pathogenesis of respira-
tory tract infection in animals (Baskerville, 1981). Hence,
animal exposed to several factors are more likely to de-
velop the disease.
The results revealed a strong correlation between
antibody level and the extent of lung lesions. Similar
observations have been reported earlier (Zamri-Saad et
al., 1996). Thus, dexamethasone-treated animals
developed lower levels of antibody and eventually
produced a much more severe pneumonia than those
without dexamethasone treatment (Chiang et al., 1990).
Gross lung lesions typical of pneumonic pasteurellosis
were determined and scored according to Zamri-Saad et
al. (1996). Results of the study indicated that double
intranasal exposures to formalin-killed Mannhaemia
haemolytica A2 significantly reducing the severity of lung
lesions. It also revealed that vaccination during stressful
conditions (group 2) resulted in most severe lung lesions
compared to other groups. This is because administra-
tion of dexamethasone post-vaccination probably has yet
to produce a maximum impact on antibody level (group
3). However, vaccinating animals prior to, during or post-
stressful conditions generally leads to a failure of the host
to develop protective antibody level against challenge
with live Mannhaemia haemolytica.
In summary, it has been demonstrated that double
intranasal exposures to formalin-killed Mannhaemia
haemolytica A2 was able to stimulate good antibody
response in goats. Dexamethasone had significantly
reduced the ability of the respiratory tract to respond to
the intranasal exposures to Mannhaemia haemolytica A2.
Thus, a vaccination programme will not be efficient if
carried out prior to, during or immediately post-stress-
ful conditions.
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